Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 48,044 shares at $15.30 ($735K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Seasonal sale ($735k) by Director — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |
| ADPT | SELL | 2023-03-29 | $20K | — | Filing → |